Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -131,211 | -87,679 | -96,046 | -128,332 | -108,543 |
| Depreciation Amortization | 839 | 2,645 | 3,516 | 3,864 | 3,559 |
| Accounts payable and accrued liabilities | -1,334 | -1,301 | -7,418 | 9,429 | 9,436 |
| Other Working Capital | -4,955 | -9,525 | -1,552 | -4,651 | 16,063 |
| Other Operating Activity | 55,918 | 16,863 | 22,111 | 4,028 | 5,222 |
| Operating Cash Flow | $-80,743 | $-78,997 | $-79,389 | $-115,662 | $-74,263 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,149 | 45,000 | -25,350 | 20,304 | 48,003 |
| PPE Investments | -130 | -19 | -943 | -892 | -2,064 |
| Purchase Of Investment | N/A | N/A | N/A | -16,390 | -13,184 |
| Investing Cash Flow | $-18,279 | $44,981 | $-26,293 | $3,022 | $32,755 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -83 | -96 | -61 | -79 | -58 |
| Common Stock Issued | 438 | 88,424 | 225 | 79,631 | 156,927 |
| Other Financing Activity | 0 | 0 | 0 | -875 | 35,479 |
| Financing Cash Flow | $355 | $88,328 | $164 | $78,677 | $192,348 |
| Beginning Cash Position | 135,774 | 81,462 | 186,980 | 220,943 | 70,103 |
| End Cash Position | 37,107 | 135,774 | 81,462 | 186,980 | 220,943 |
| Net Cash Flow | $-98,667 | $54,312 | $-105,518 | $-33,963 | $150,840 |
| Free Cash Flow | |||||
| Operating Cash Flow | -80,743 | -78,997 | -79,389 | -115,662 | -74,263 |
| Capital Expenditure | -130 | -19 | -943 | -892 | -2,064 |
| Free Cash Flow | -80,873 | -79,016 | -80,332 | -116,554 | -76,327 |